Abstract
A number of novel benzo-1,3-dioxolo-, benzothiazolo-, pyrido-, and quinolino-fused 5H-benzo[d]pyrazolo[5,1-b][1,3]-oxazines and 1H-pyrazoles were synthesized utilizing an easy and effective N,N-bond forming heterocyclization reaction. In so doing, the substrate scope of this heterocyclization reaction, which starts with o-nitroheterocyclic aldehydes, was expanded to provide several unique heterocyclic compounds for biological screening. This work further demonstrates the versatility of this simple, base-mediated, one-pot heterocyclization method in the construction of novel heterocycles.
Indazoles (e.g., benzo-fused pyrazoles) have been shown to display a wide array of biological activities, including anti-angiogenic,1 antiviral,2 and anti-inflammatory applications.3 These biological activities have prompted synthetic chemists to develop new methodologies to synthesize and functionalize the indazole ring system.3 In that regard, the literature contains examples of heterocyclization routes to indazole derivatives;4-5 however, of the two indazole isomers, 2H-indazoles are considerably less studied.6 Of special interest, pyrazolopyridines have been shown to have improved log P and water solubilities compared to indoles and indazoles exhibiting protein kinase B/Akt inhibitory activities7,4 and, more recently, 4-(pyrazol-4-yl)pyrimidines have been shown to selectively inhibit CDK4/6 (see Figure 1).8
Figure 1.
Pyrazolopyridine and 4-(pyrazol-4-yl)pyrimidines inhibitors.
The benzo-1,3-oxazine ring system has also been shown to exhibit antihypertensive affects,9 potency as antirheumatic agents,10 and antianginal acitivity.11 In contrast, heterocycle-fused 5H-benzo[d]pyrazolo[5,1-b][1,3]-oxazines, to the best of our knowledge, are unknown. This, together with the biological potential and intriguing structures of these compounds, prompted us to study the synthesis of this novel class of heterocycles.
We have previously demonstrated that 3-alkoxy-2H-indazoles (Scheme 1a) and 5H-indazolo[3,2-b]benzo[d]-1,3-oxazines (Scheme 1b) can be obtained from o-nitroarylmethylamines via an N,N-bond forming heterocyclization reaction by treatment with KOH and water in alcoholic solvent.12 It was also found that 5H-indazolo[3,2-b]benzo[d][1,3]-oxazines can be obtained in a one-pot reaction starting with o-nitrobenzaldehyde.12e We envisaged that these methods (Scheme 1a/b) could be extended to the synthesis of a variety of novel heterocyclic analogs by, for example, introduction of a nitrogen atom in the benzo ring of 2H-indazoles or in any of the rings fused to this benzo ring (Scheme 1c). Indeed, a host of unique heterocycles can be envisioned in which the pyrazole ring is the common denominator and we report here that a number of benzo-1,3-dioxolo-, benzothiazolo-, pyrido-, quinolino-fused 5H-benzo[d]-pyrazolo[5,1-b]-[1,3]-oxazines and 1H-pyrazoles are accessible in moderate to high yields (35-88%) via this N,N-bond forming heterocyclization reaction.
Scheme 1.
Synthetic routes to benzo-fused [(a) and (b)]and heterocycle-fused (c) pyrazoles.
Scheme 2 demonstrates that o-nitroheterocyclic amine 3 can be accessed from either o-nitroheterocyclic aldehydes (1; Method A) or o-nitroheterocyclic halides (2; Method B). In Method A, the targeted o-nitroarylmethylamine 3 is obtained in nearly quantitative yield by utilizing an excess of amine. Moreover, the resulting o-nitroarylmethylamine generally does not require purification and crude 3 can be used directly in the subsequent heterocyclization with no significiant loss in yield or complication in product isolation/purification. In Method B, the starting o-nitroheterocyclic halide 2 is prepared in low yield (benzylic bromination; 30-40%) making this a generally less effective route to o-nitroarylmethylamine 3.
Scheme 2.
Synthesis of o-nitroarylmethylamines.a
aMethod A: R1NH2 + acetic acid in MeOH; then NaBH3CN/MeOH.
Method B: R1NH2 (excess) in refluxing MeOH.
All o-nitroheterocyclic aldehydes (4a-e, Scheme 3) except for 4e, which was commercially available, were synthesized according to literature procedures.13 Our targeting of heterocycle-fused pyrazoles started with treatment of the specific o-nitroheterocyclic aldehyde 4 with 2-aminobenzyl alcohol or p-bromoaniline followed by reduction of the resulting anil with NaBH3CN to obtain the o-nitroheterocyclic amine 3 (Scheme 3).
Scheme 3.
Route to heterocycle-fused pyrazoles.
As previously mentioned, these amine intermediates were not isolated, but were further treated with aqueous KOH in iPrOH (for 5a-e) or in MeOH (for 6a-e) to effect the heterocyclization leading to a series of heterocycle-fused pyrazole derivatives. The overall yields ranged from 80-85% for 5a-e and 44-67% for 6a-e (Scheme 3).
Interestingly, the heterocyclization reactions which give pyrido- and quinolino-fused 1H-pyrazoles (see Table 1) were effected at room temperature – a deviation from the previously reported methods (Scheme 1a/b) where heating to 60°C was required. This relative ease of formation of heterocycles 5a-c and 6a-c is likely due to the increased acidity of the benzylic hydrogen 4a-c. In the synthesis of 5a-c, iPrOH was used as solvent in the N,N-bond forming heterocylization reactions; when MeOH was used, LC/MS of the crude reaction mixture indicated some indazolone formation.14 However, when targeting heterocycle-fused pyrazoles 6a-c, MeOH was used as reactant and solvent and no indazolone was observed.
Table 1.
Synthesis of pyrido- and quinolino-fused 5H-benzo[d]pyrazolo[5,1-b][1,3]-oxazines and 1H-pyrazoles.a,b
o-nitroheterocyclic aldehydec![]() |
product | yield |
---|---|---|
![]() |
![]() |
85% |
![]() |
![]() |
67% |
![]() |
![]() |
81% |
![]() |
![]() |
61% |
![]() |
![]() |
80% |
![]() |
![]() |
55% |
Products were characterized by 1H, 13C NMR, IR, and ESI MS.
Isolated yields after purification by chromatography on slica gel.
See 4a-c in Scheme 3.
Next, a study of quinolino- and benzo-1,3-dioxolo-fused analogs of 5 and 6 were explored (Table 2). Compounds 5d-e and 6d-e were synthesized by the same methods employed for 5a-c/6a-c (Scheme 3). It is interesting to note that reactions of 4e → 5e and 4e → 6e proceed well (yields of 44% and 88%, respectively) despite the fact that starting material 4e is relatively electron rich.
Table 2.
Synthesis of quinolino- and benzo-1,3-dioxolo-fused 5H-benzo[d]pyrazolo[5,1-b][1,3]-oxazines and 1H-pyrazoles.a,b
o-nitroheterocyclic aldehydec![]() |
product | yield |
---|---|---|
![]() |
![]() |
78% |
![]() |
![]() |
54% |
![]() |
![]() |
88% |
![]() |
![]() |
44% |
Products were characterized by 1H, 13C NMR, IR, and ESI MS.
Isolated yields after purification by chromatography on silica gel.
See 4d-e in Scheme 3.
Benzothiazolo-fused pyrazoles 11 and 12 (Scheme 4) are additional examples of benzo-fused heterocyclic pyrazoles attainable by this method. To synthesize these compounds, the key synthetic intermediate, 6-bromomethyl-7-nitrobenzothiazole (10), was synthesized in three steps (25% overall yield) from 6-methyl-2-benzothiazolamine (7).15,16 Step one involved deamination of 7 with phosphoric acid and sodium nitrite followed by reduction with hypophosphorous acid to give 6-methyl-benzothiazole (8). Subsequent regioseletive nitration delivered 6-methyl-7-nitrobenzothiazole (9) in improved yield (95%) when purified by flash chromatography instead of recrystallization. Nitrobenzothiazole 9 was then reacted with stoichiometric NBS in carbon tetrachloride (AIBN catalyst), under reflux for 12 h, to give 7-bromomethyl-6-nitrobenzothiazole (10) in 40% yield. Benzyl bromide 10 was then N-alkylated with excess 2-aminobenzyl alcohol, or p-bromoaniline, to generate the corresponding o-nitroarylmethylamines in MeOH which, without isolation, was treated with aqueous KOH in iPrOH (→ 11) or in MeOH (→ 12) to deliver benzothiazolo-fused pyrazoles 11 and 12 in 43% and 35% yields, respectively.
Scheme 4.
Synthesis of benzothiazolo-fused 5H-benzo-[d]pyrazolo[5,1-b][1,3]-oxazines and 1H-pyrazoles.a,b
aProducts were characterized by 1H, 13C NMR, IR, and ESI MS.
bIsolated yields after purification by chromatography on silica gel.
Finally, with these successes in preparing the unique heterocycles delineated above through this easy and effective N,N-bond forming heterocyclization methodology, we attempted to synthesize thiophene-fused pyrazole 15 (Scheme 5). N-((2-Nitrothiophen-3-yl)methyl)aniline (14) was obtained from 2-nitrothiophene-3-carbaldehyde17 (13) and 2-fluoroaniline by reductive amination. Subjecting 14 to heterocyclization conditions at 0 °C (significant decomposition ensued at room temperature), failed to deliver the anticipated thieno-fused pyrazole 15. Rather, the major product of this reaction proved to be 2-fluoro-N-((2-nitrothiophen-3-yl)methylene)aniline (17).18 We speculate that nitroso imine 16 is the initial product of this reaction,12a,b but subsequent nitroso → nitro air oxidation19 out-competes N,N-bond formation to deliver 17 rather than the targeted heterocycle 15. This difficulty in formation of thieno-fused 1H-pyrazole 15 appears to derive from the weak acidity of the sp3 hybridized proton of 16’, which thus impedes 1,4-elimination of water. However, this tentative explanation remains to be supported by further investigation.
Scheme 5.
Attempted synthesis of a thieno-fused 1H-pyrazole.
In summary, several unique pyrazole-based heterocycles were synthesized by a one-pot, N,N-bond forming heterocyclization of o-nitroarylmethylamines. These novel heterocycles have been submitted to the NIH Molecular Libraries Small Molecule Repository (MLSMR) for high-throughput biological screening. In view of the utility of this N,N-bond forming heterocyclization, which has been demonstrated in the synthesis of a wide variety of often complex heterocycles in this work as well as in six earlier pulications,12,14 we propose to call this method the “Davis-Beirut” reaction in recognition of the merits of international collaboration.
Supplementary Material
Acknowledgments
Financial support was provided by the National Science Foundation (CHE-0910870, CHE-0449845) and the National Institutes of Health (GM089153). B.A. thanks the Bristol-Myers Squibb Graduate Minority Chemist Fellowship and Alfred P. Sloan Minority Ph.D. Program for fellowship support.
Footnotes
Supporting Information:Full experimental details and characterization data (IR, 1H NMR, 13C NMR, and ESI MS) of all new compounds are available free of charge via the Internet at http://pubs.acs.org.
References
- 1.Huang L-J, Shih M-L, Chen H-S, Pan S-L, Teng C-M, Lee F-Y, Kuo S-C. Bioorg Med Chem. 2006;14:528. doi: 10.1016/j.bmc.2005.08.032. [DOI] [PubMed] [Google Scholar]
- 2.Kim D, Wang L, Caldwell CG, Chen P, Finke PE, Oates B, MacCoss M, Mills SG, Malkowitz L, Gould SL, DeMartino JA, Springer MS, Hazuda D, Miller M, Kessler J, Danzeisen R, Carver G, Carella A, Holmes K, Lineberger J, Schleif WA, Emini EA. Bioorg Med Chem Lett. 2001;11:3103. doi: 10.1016/s0960-894x(01)00655-2. [DOI] [PubMed] [Google Scholar]
- 3.Schmidt A, Beutler A, Snovydovych B. Euro J Org Chem. 2008;4073 [Google Scholar]
- 4.Heller ST, Natarajan SR. Org Lett. 2007;9:4947. doi: 10.1021/ol701784w. [DOI] [PubMed] [Google Scholar]
- 5.(a) Hurst J. J Chem Soc (C) 1968;1487 [Google Scholar]; (b) Foster H, Hurst J. J Chem Soc Perkin Trans I. 1973;319 [Google Scholar]; (c) Chapman D, Hurst J. J Chem Soc Perkin Trans I. 1980;2398 [Google Scholar]
- 6.(a) Stadlbauer W, Camp N. In: Science of Synthesis: Houben-Weyl Methods of Molecular Transformations. Bellus D, Ley SV, Noyori R, Regitz M, Schaumann E, Shinkai E, Thomas EJ, Trost BM, Reider PJ, editors. Vol. 12. Thieme; Stutggart: 2002. p. 227. [Google Scholar]; (b) Wu C, Fang Y, Larock RC, Shi F. Org Lett. 2010;12:2234. doi: 10.1021/ol100586r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhu G-D, Gandhi VB, Gong J, Thomas S, Woods KW, Song X, Li T, Diebold RB, Luo Y, Liu X, Guan R, Klinghofer V, Johnson EF, Bouska J, Olson A, Marsh KC, Stoll VS, Mamo M, Polakowski J, Campbell TJ, Martin RL, Gintant GA, Penning TD, Li Q, Rosenberg SH, Giranda VL. J Med Chem. 2007;50:2990. doi: 10.1021/jm0701019. [DOI] [PubMed] [Google Scholar]
- 8.Cho YS, Borland M, Brain C, Chen CH-T, Cheng H, Chopra R, Chung K, Groarke J, He G, Hou Y, Kim S, Kovats S, Lu Y, O’Reilly M, Shen J, Smith T, Trakshel G, Vogtle M, Xu M, Sung MJ. J Med Chem. 2010;53:7938. doi: 10.1021/jm100571n. [DOI] [PubMed] [Google Scholar]
- 9.Clark RD, Caroon JM, Kluge AF, Repke DB, Roszkowski AP, Strosberg AM, Baker S, Bitter SM, Okada MD. J Med Chem. 1983;26:657. doi: 10.1021/jm00359a007. [DOI] [PubMed] [Google Scholar]
- 10.Matsuoka H, Ohi N, Mihara M, Suzuki H, Miyamoto K, Maruyama N, Tsuji K, Kato N, Akimoto T, Takeda Y, Yano K, Kuroki T. J Med Chem. 1997;40:105. doi: 10.1021/jm9605288. [DOI] [PubMed] [Google Scholar]
- 11.Benedini F, Bertolini G, Cereda R, Dona G, Gromo G, Levi S, Mizrahi J, Sala A. J Med Chem. 1995;38:130. doi: 10.1021/jm00001a018. [DOI] [PubMed] [Google Scholar]
- 12.(a) Kurth MJ, Olmstead MM, Haddadin MJ. J Org Chem. 2005;70:1060. doi: 10.1021/jo048153i. [DOI] [PubMed] [Google Scholar]; (b) Mills AD, Nazer MZ, Haddadin MJ, Kurth MJ. J Org Chem. 2006;71:2687. doi: 10.1021/jo0524831. [DOI] [PubMed] [Google Scholar]; (c) Mills AD, Maloney P, Hassanein E, Haddadin MJ, Kurth MJ. J Comb Chem. 2007;9:171. doi: 10.1021/cc060109o. [DOI] [PubMed] [Google Scholar]; (d) Butler JD, Solano DM, Robins LI, Haddadin MJ, Kurth MJ. J Org Chem. 2008;73:234. doi: 10.1021/jo702067z. [DOI] [PubMed] [Google Scholar]; (e) Solano DM, Butler JD, Haddadin MJ, Kurth MJ. Org Synth. 2010;87:339. [Google Scholar]
- 13.(a) Niu C, Li J, Doyle TW, Chen S-H. Tetrahedron. 1998;54:6311. [Google Scholar]; (b) Vetelino MG, Coe JW. Tetrahedron Lett. 1994;35:219. [Google Scholar]; (c) Yan M-C, Tu Z, Lin C, Ko S, Hsu J, Yao C-F. J Org Chem. 2004;69:1565. doi: 10.1021/jo030070z. [DOI] [PubMed] [Google Scholar]; (d) Godard A, Queguiner G. J Heterocycl Chem. 1980;17:465. [Google Scholar]; (e) Couch GD, Knox RJ, Moody CJ. Tetrahedron. 2008;64:2816. [Google Scholar]
- 14.Oakdale JS, Solano DM, Fettinger JC, Haddadin MJ, Kurth MJ. Org Lett. 2009;11:2760. doi: 10.1021/ol900891s. [DOI] [PubMed] [Google Scholar]
- 15.Matveev M, Ponyaev AI, El’tsov AV. Russ J Gen Chem. 2001;71:1286. [Google Scholar]
- 16.Katritzky AR, Rogovoy BV, Chassaing C, Vvedensky V, Forood B, Flatt B, Nakai H. J Heterocycl Chem. 2000;37:1655. [Google Scholar]
- 17.Makosza M, Owczarczyk Z. Tetrahedron Lett. 1987;28:3021. [Google Scholar]
- 18.The structure of 17 has been independently varified through its direct preparation by condensation of 13 with o-fluoroaniline; see Supporting Information.
- 19.We have observed nitroso → nitro air oxidation in a related system (o-nitrosoaniline → o-nitroaniline); unpublished results.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.